Analystreport

Flexion Therapeutics Inc (NASDAQ: FLXN) was given a new $39.00 price target on by analysts at Wells Fargo & Co. They now have a "buy" rating on the stock.

Flexion Therapeutics, Inc.  (FLXN) 
Last flexion therapeutics, inc. earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.flexiontherapeutics.com